单细胞分析:技术成长机会
市场调查报告书
商品编码
1398862

单细胞分析:技术成长机会

Single-cell Analysis: Technology Growth Opportunities

出版日期: | 出版商: Frost & Sullivan | 英文 68 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

单细胞分析的技术进步将带来新的诊断和治疗机会。

单细胞分析可以透过研究细胞内基因组学、转录组学、蛋白质组学、代谢组学和其他细胞间相互作用来诊断异质细胞群样本的状态。它将帮助我们更好地了解肿瘤微环境,并根据新发现的不同肿瘤类型的知识来开发药物。这种分析方法产生的大量资料可以深入了解基因表现和决定病理的其他因素。

这种方法引起了投资者和研究机构的关注,因为它推进了现有的诊断和药物研发方法,但它也存在技术挑战(必须透过技术平台的进步来克服),并且存在一个以大测序为主导的高度竞争的环境已经成长为提供小公司无法提供的端到端解决方案的公司。

许多公司在基因组和转录组层面进行单细胞分析,但只有少数公司进行蛋白质体学和多组体学单细胞分析。技术的进步有助于避免繁琐的过程,例如在文库製备过程中透过独特的条码过程进行单细胞分离。空间体学和活细胞测序等现代方法也补充了现有的单细胞分析过程。这种方法的主要挑战之一是测序结果的资料分析,这是透过云端平台解决的,无需任何生物资讯经验即可操作。使用这种分析方法对尚未理解的主题进行研究有很大的空间,我们确信这种方法将在未来十年内显着增长,希望不仅能改善癌症的诊断,还能改善其他疾病的诊断。

该研究确定了该行业的挑战、驱动因素、新技术平台和成长机会,并预测了成长前景。它还确定了利益相关相关人员和市场参与企业应该利用的着名併购、资金筹措和合作伙伴关係,并概述了相关人员生态系统。

目录

战略问题

  • 为什么成长如此困难?策略要务 8 (TM):阻碍成长的因素
  • 战略要务8(略)
  • 关键策略倡议对单细胞分析产业的影响
  • 成长机会推动Growth Pipeline Engine(TM)
  • 调查方法

调查范围和细分

  • 分析背景和范围
  • 分割

成长机会分析

  • 生长促进因子
  • 成长抑制因素

介绍

  • 单细胞分析简介及其必要性
  • 单细胞定序流程开发时间表
  • 单细胞分析应用

技术简介

  • 单细胞分离
  • 单细胞分离技术-商业化解决方案
  • 单细胞文库製备
  • 单细胞文库製备-创新
  • 单细胞序列
  • 单细胞定序平台
  • 单细胞生物资讯学
  • 用于单细胞分析的生物资讯工具

为单细胞分析提供动力的技术推动者

  • 人工智慧和机器学习在单细胞分析中的影响力日益增强
  • 空间体学技术的发展补充了单细胞分析技术
  • 微流控技术在单细胞分析的应用

单细胞分析的最新技术进展

  • 活细胞测序或时间分析可在不损坏细胞的情况下提供空间资讯
  • 将单细胞与其他技术相结合为治疗方法开发提供了深刻的见解
  • 3D 基因组技术可以更好地描述细胞环境及其异质性
  • 单细胞发现研究的前景
  • 大学单细胞分析研究概况

单细胞分析的趋势与发展

  • 过去五年平台开发的增加
  • 单细胞分析应用扩展到肿瘤学之外
  • 单细胞和空间分析的改进将透过新发现增强精准医学
  • 相关人员生态系统
  • 单细胞分析策略伙伴关係
  • 资金筹措生态系统
  • 主导单细胞和空间基因组併购的综合解决方案提供商
  • 与单细胞分析相关的专利申请和津贴稳步增加
  • 单细胞分析生态系的形势

成长机会宇宙

  • 成长机会 1:单细胞分离和文库製备的进步可改善整体工作流程
  • 成长机会 2:将单细胞分析的范围扩展到精准肿瘤学之外
  • 成长机会 3:改进单细胞资料科学,快速获得定序资料中有意义的见解

附录

  • 技术成熟度等级 (TRL):解释

下一步

简介目录
Product Code: DAC1

Technological advancements in single-cell analysis propel new diagnostic and therapeutic opportunities.

Single-cell analysis can diagnose a condition in heterogenous cell population samples by studying genomics, transcriptomics, proteomics, metabolomics, and other cellular interactions in cells. It helps to understand a tumor microenvironment better and develop drugs based on newly uncovered knowledge of various types of tumors. The rich data provided through this method of analysis gives in-depth insight into gene expression and other factors determining a pathological condition.

As this method is an advancement to already existing methods of diagnosis and drug discovery, it is gaining the attention of investors and research institutions, although there are a few challenges in terms of technology (which must be navigated through advancements in technology platforms) and the monopoly of large sequencing companies that have grown to provide end-to-end solutions that cannot be provided by small and mid-sized companies, creating an intensely competitive environment.

Many companies perform single-cell analysis at the genomic and transcriptomic levels; however, only a few do the same in proteomic and multi-omics single-cell resolution. Technology advancements are helping to bypass tedious processes, such as single-cell separation through a unique barcoding process during library preparation. Modern methods, including spatial omics and live-cell sequencing, are also complementing the existing single-cell analysis process. One of the major challenges in this method is the data analysis of sequenced results, which is being tackled through cloud platforms that operate without the need for prior bioinformatics experience. There is significant scope for research on topics that are underexplored in this method of analysis, which ensures good growth of this technique in the next decade and promises improved diagnosis not only for cancer but also for other diseases.

This study identifies the challenges, drivers, new technology platforms, and growth opportunities in this space and foresees a growth outlook. It also provides an overview of the stakeholder ecosystem, identifying notable mergers and acquisitions, funding, and partnerships for stakeholders and market participants to leverage.

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Single-cell Analysis Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™
  • Research Methodology

Scope and Segmentation

  • Context and Scope of Analysis
  • Segmentation

Growth Opportunity Analysis

  • Growth Drivers
  • Growth Restraints

Introduction

  • Introduction to Single-cell Analysis and the Need for It
  • Single-cell Sequencing Process Development Time Line
  • Single-cell Analysis Applications

Technology Snapshot

  • Single-cell Isolation
  • Single-cell Isolation Technologies-Commercialized Solutions
  • Single-cell Library Preparation
  • Single-cell Library Preparation-Innovation
  • Single-cell Sequencing
  • Single-cell Sequencing Platforms
  • Single-cell Bioinformatics
  • Bioinformatics Tools Used in Single-cell Analysis

Technology Enablers Bolstering Single-cell Analysis

  • Growing Influence of AI and ML in Single-cell Analysis
  • Spatial Omics Technologies Evolving to Compliment Single-cell Analysis Technology
  • Microfluidic Technologies in Single-cell Analysis

Recent Technological Advancements in Single-cell Analysis

  • Live-cell Sequencing or Temporal Analysis Providing Spatial Information Without Damaging Cells
  • A Combination of Single-cell and Other Technologies Providing Deeper Insights for Therapy Development
  • 3D Genome Technologies Offering a Better Depiction of the Cell Environment and Its Heterogeneity
  • Single-cell Exploratory Research Landscape
  • Snapshot of University Research in Single-cell Analysis

Trends and Developments in Single-cell Analysis

  • Increasing Number of Platform Developments in the Last 5 Years
  • Applications of Single-cell Analysis to Expand Beyond Oncology
  • Improved Single-cell and Spatial Analysis to Strengthen Precision Medicine Through New Discoveries
  • Stakeholder Ecosystem
  • Single-cell Analysis Strategic Partnerships
  • Funding Ecosystem
  • Integrated Solution Providers Dominating M&As in Single-cell and Spatial Genomics
  • Steadily Increasing Patent Filings and Grants for Single-cell Analysis
  • Landscape of the Single-cell Analysis Stakeholder Ecosystem

Growth Opportunity Universe

  • Growth Opportunity 1: Advances in Single-cell Isolation and Library Preparation Improving Overall Workflow
  • Growth Opportunity 2: Widening Applicability of Single-cell Analysis Beyond Precision Oncology
  • Growth Opportunity 3: Improvement in Single-cell Data Science for Rapid and Meaningful Insights of Sequenced Data

Appendix

  • Technology Readiness Levels (TRL): Explanation

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • Legal Disclaimer